What it sells
AI healthcare ("medical world model").
Business model breakdown
Buyer: who owns the budget?
UnverifiedHospital administrators and clinical department heads (pathology, imaging, surgery, outpatient) for hospitals; medical and research teams at pharma.
Trigger: what makes them buy now?
UnverifiedHospitals need to move from isolated AI point tools to one evolvable AI infrastructure layer across imaging, pathology, clinical and patient-service workflows; pharma teams need faster research evidence work.
Workflow: what inputs become what output?
Connects imaging, pathology, EMR, patient service and research into one hospital AI foundation, with department-level modules for screening, diagnosis, reporting, surgical planning and a robotic pathology-slide workflow.
Economics: what it saves and how it charges
Sells smart-hospital software modules and an embodied pathology device to hospitals, plus research tools to pharma; site claims 30+ device registration certificates, 1000+ patents and 50,000+ physicians empowered.
Distribution: how it reaches customers
UnverifiedDirect enterprise and hospital sales with a Contact Us form; international deployments through hospital groups in Singapore, Hong Kong, Macau and Indonesia.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2025-12-01 | — | CNY 1B | — | sh.chinanews.com.cn |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-13.